VISIE’s first production units of its computer vision system have come off the line at its contract manufacturer. The sub-component technology, which lets robotics and navigation manufacturers build robots that see what surgeons see, is now ready for partners to integrate.
The first batch of VISIE’s computer vision systems moves directly into verification and validation, with the next units off the line shipping to integration partners as development kits. The system is built under a full quality management system and equipped with an API for rapid integration. It also features VISIE’s proprietary Continuous Anatomic Auto Tracking that enables surgical robotic systems to see and continuously track anatomy, without pins, arrays, or manual registration.
“This is much more than another prototype,” said Doug Fairbanks, CEO of VISIE Inc. “The last nine months have been transformational. For years, the question was whether this technology could work. Now the question is how fast our partners can integrate it and take it to market. VISIE is ready to ship dev kits.”
The development kits will support partner system integration, technical evaluation, and continued product development. VISIE’s computer vision system is not yet FDA-cleared and is not available for sale or clinical use.
VISIE’s first production units of its computer vision system have come off the line at its contract manufacturer. The sub-component technology, which lets robotics and navigation manufacturers build robots that see what surgeons see, is now ready for partners to integrate.
The first batch of VISIE’s computer vision systems moves directly into...
VISIE’s first production units of its computer vision system have come off the line at its contract manufacturer. The sub-component technology, which lets robotics and navigation manufacturers build robots that see what surgeons see, is now ready for partners to integrate.
The first batch of VISIE’s computer vision systems moves directly into verification and validation, with the next units off the line shipping to integration partners as development kits. The system is built under a full quality management system and equipped with an API for rapid integration. It also features VISIE’s proprietary Continuous Anatomic Auto Tracking that enables surgical robotic systems to see and continuously track anatomy, without pins, arrays, or manual registration.
“This is much more than another prototype,” said Doug Fairbanks, CEO of VISIE Inc. “The last nine months have been transformational. For years, the question was whether this technology could work. Now the question is how fast our partners can integrate it and take it to market. VISIE is ready to ship dev kits.”
The development kits will support partner system integration, technical evaluation, and continued product development. VISIE’s computer vision system is not yet FDA-cleared and is not available for sale or clinical use.
Copy to clipboard 
